Skip to main content

Day: October 12, 2021

Prometheus Biosciences to Present at Jefferies Virtual Next Generation IBD Therapeutics Summit

SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) — Prometheus Biosciences, Inc. (Nasdaq: RXDX), today announced that Mark McKenna, Chairman and Chief Executive Officer and Allison Luo, M.D., Chief Medical Officer, will participate in a fireside chat at the Jefferies Virtual Next Generation IBD Therapeutics Summit on Tuesday, October 19, 2021 at 11:30 a.m. ET. A live and archived webcast of the fireside chat will be available via the Events & Webcasts section of the Prometheus Biosciences website. A replay of the presentation will be available for 30 days following the event. About Prometheus Biosciences Prometheus Biosciences, Inc. is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment...

Continue reading

Seacoast Bank Hires Strategic Leadership for Further Market Expansion in Florida

STUART, Fla., Oct. 12, 2021 (GLOBE NEWSWIRE) — Seacoast Banking Corporation of Florida (NASDAQ: SBCF), one of the largest community banks based in Florida, continues making investments and expanding its footprint across the state with key additions to its leadership and commercial banking team. The Company announced today that it is expanding its operations to service north Florida. Seacoast has added Brannon Fitch to its leadership team as executive vice president and regional president for north Florida to lead the bank’s strategic expansion into the region. Fitch joins Seacoast after almost two decades of executive leadership experience at BB&T, and will lead Seacoast’s strategic expansion into this important and fast-growing market. Additionally, Seacoast continues investing in expanding the footprint of its real estate...

Continue reading

Sarepta Therapeutics Announces Proposed $500,000,000 Public Offering of Common Stock

CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (Nasdaq:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it is offering to sell, subject to market and other conditions, $500,000,000 in shares of its common stock in an underwritten public offering. Sarepta also intends to grant the underwriters a 30-day option to purchase up to an additional $75,000,000 in shares of its common stock. Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Credit Suisse Securities (USA) LLC are acting as the underwriters of the proposed offering. Sarepta intends to use the net proceeds from the offering principally for the continuation of, and initiation of further, clinical trials, commercialization, manufacturing, business development activities,...

Continue reading

mdf commerce evolves its product offering with new k-ecommerce Integrated Payment solution

The payment processing software is a testament to the Company’s ability to innovate and to generate new revenue streams. MONTREAL, Oct. 12, 2021 (GLOBE NEWSWIRE) — mdf commerce inc. (TSX:MDF), a leader in SaaS commerce technology solutions, today announced the launch of its k-ecommerce Integrated Payment solution (KIP), an omnichannel payment processing software. This digital solution offers invoice payment and transaction processing, and offers merchants a competitively priced gateway with industry-leading account services. This innovative product demonstrates the commitment of mdf commerce to expand and enhance its offering and diversify its revenue streams. KIP offers a simple, efficient, and affordable solution for Microsoft Dynamics GP and Business Central (BC) users who want to offer online payments. Approximately 15,000...

Continue reading

TrustCo to Release Third Quarter 2021 Results on October 21, 2021; Conference Call on October 22, 2021

GLENVILLE, N.Y., Oct. 12, 2021 (GLOBE NEWSWIRE) — TrustCo Bank Corp NY (TrustCo, Nasdaq: TRST) today announced that it will release third quarter 2021 results after the market close on October 21, 2021. Results are released on the 21st of the reporting months (January, April, July and October), or on the next day that equity markets are open if the 21st falls on a Friday, weekend or holiday. A conference call to discuss the results will be held at 9:00 a.m. Eastern Time on October 22, 2021. Those wishing to participate in the call may dial toll-free for the United States at 1-844-200-6205, for Canada at 1-833-950-0062, and all other locations at 1-929-526-1599, Access code 817092. A replay of the call will be available for thirty days by dialing toll-free for the United States at 1-866-813-9403, for Canada at 1-226-828-7578, and...

Continue reading

J & J SNACK FOODS SCHEDULES FOURTH QUARTER CONFERENCE CALL

PENNSAUKEN, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) — J & J Snack Foods Corp. (NASDAQ-JJSF) announced today that its conference call to discuss fourth quarter 2021 results is scheduled for Tuesday November 16th at 10:00 am Eastern time. The phone number and confirmation number for the call are 1 (847) 585-4422 and 9408 458#. The Company stated that it expects to release its results for the quarter ended September 25th, 2021, at 4:15 pm Eastern time on Monday November 15th. J&J Snack Foods Corp. (NASDAQ: JJSF) is a leader and innovator in the snack food industry, providing innovative, niche and affordable branded snack foods and beverages to foodservice and retail supermarket outlets. Manufactured and distributed nationwide, our principal products include SUPERPRETZEL, the  #1 soft pretzel brand in the world, as well as internationally...

Continue reading

EarthRenew Announces Shares Issued for Additional Consideration (Earn-Out) on Replenish Nutrients Acquisition

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 12, 2021 (GLOBE NEWSWIRE) — EarthRenew Inc. (CSE: ERTH; OTCQB: VVIVF) (“EarthRenew” or the “Company”) announces that, further to its press release of May 4, 2021 with respect to the acquisition (the “Replenish Acquisition”) of Replenish Nutrients Ltd. pursuant to a share purchase agreement (the “Share Purchase Agreement”) dated effective May 1, 2021, the first earn-out period ending June 30, 2021 with respect to the Replenish Acquisition resulted in earn-out payments owing by the Company in the aggregate amount of $999,070.00, of which $599,441.93 was settled by the issuance of 2,840,957 common shares of the Company, each with a deemed issuance price of $0.211 (being the 30-day volume weighted average trading price of the Company’s...

Continue reading

Santander Chile returns to the Swiss market with a successful five-year transaction

In a challenging environment, Santander Chile confirms its excellent position with international investors. The bank issued CHF 190 million over five years in the public market SANTIAGO, Chile, Oct. 12, 2021 (GLOBE NEWSWIRE) — Santander Chile (NYSE: BSAC) (SSE: BSANTANDER) returns to the international market and successfully issues a bond in Swiss francs for CHF 190 million (equivalent to US $ 205 million) for a five-year term, achieving a spread of 60 basis points over the reference rate, which is equivalent to a coupon of 0.2975%. This issue once again confirms the excellent reception of Santander Chile’s credit in foreign markets, at times of local uncertainty. This transaction received great interest and demand from investors, and represents the second in this market during the year, after the placement of CHF 150 million...

Continue reading

good natured Products Inc. Announces $50 Million Financing and Commercial Agreement with US Food Producer

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Oct. 12, 2021 (GLOBE NEWSWIRE) — good natured Products Inc. (the “Company” or “good natured®”) (TSX-V: GDNP), a North American leader in earth-friendly plant-based products, today announces it has filed a preliminary short form prospectus with the securities regulatory authorities in all provinces of Canada except Quebec, in connection with an anticipated offering (the “Offering“) of $15 million aggregate principal amount of convertible unsecured subordinated debentures maturing October 31, 2026 (the “Debentures”). The Offering is being conducted on an overnight marketed basis by a syndicate of underwriters (the “Underwriters”) led by National Bank Financial Inc. (“NBF”) and Beacon Securities Limited (“Beacon”). The...

Continue reading

Festi hf.: Buy-back programme week 41 – end of buy-back

In week 41, Festi purchased in total 443,689 own shares for total amount of 94,118,379 ISK as follows:Week Date Time Purchased shares Share price Purchase price41 11.10.2021 11:00:44 3.026 212,000 641.51241 11.10.2021 12:07:07 9.800 212,000 2.077.60041 11.10.2021 13:07:29 150.000 213,000 31.950.00041 11.10.2021 15:24:38 87.174 212,000 18.480.88841 12.10.2021 10:10:30 100.000 212,000 21.200.00041 12.10.2021 14:20:02 93.689 211,000 19.768.379      443.689   94.118.379This announcement of purchase of own shares is in accordance with the buy-back programme announced 20 September 2021 to Nasdaq OMX Iceland. Festi has purchased in total 3,500,000 own shares for 732,506,058 ISK and has finished the buy-back. Before the purchase Festi held 2,500,000 own shares or 0.77% of issued shares but owns now 6,000,000 own shares...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.